Milk-Derived Extracellular Vesicles as Multifunctional Therapeutic Platforms in Human Health, Nutrition, and Diagnostics
Recent Progress in Nutrition · 09.06.2026 · 06 (02) · 1-43
DOI: 10.21926/rpn.2602007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Recent Progress in Nutrition, online erschienen am 09.06.2026. Verfasst von Diwakar Singh und 1 weiteren Autor:innen. Die Arbeit nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Extracellular vesicles (EVs) are nanoscale, lipid-bilayer carriers that mediate intercellular communication by transporting proteins, lipids, and nucleic acids, thereby influencing physiological and pathological processes. This review integrates current knowledge on milk-derived and human extracellular vesicles, highlighting their multifunctional roles in therapy, diagnostics, and regenerative medicine. Milk-derived EVs (MEVs), small EVs (sEVs), and human milk EVs (hMEVs) demonstrate unique stability, biocompatibility, and cross-barrier transport, enabling oral and systemic therapeutic applications. These vesicles exhibit immunomodulatory, anti-inflammatory, and drug-delivery potential, making them promising platforms for tissue repair, intestinal integrity, metabolic regulation, and microbiota modulation. In oncology, EVs contribute to tumor progression, metastasis, and immune regulation, while engineered or milk-derived vesicles provide biocompatible platforms for targeted therapy and diagnostics. Integration with biomaterials, nanotechnology, and artificial intelligence enhances EV engineering, cargo optimization, and therapeutic precision. Despite their translational promise, clinical applications remain constrained by heterogeneity, inefficiencies in isolation, lack of standardized protocols, and incomplete mechanistic understanding. Scalable production, reproducible purification workflows, cargo-loading strategies, and safety assessments are essential for advancing EV-based therapeutics from preclinical studies to clinical interventions. Continued exploration of cross-species and biofluid-derived EVs, along with improved characterization and functional analyses, will facilitate their integration into regenerative medicine, drug delivery, nutritional interventions, and minimally invasive diagnostics. Overall, this review highlights extracellular vesicles as versatile nanoscale platforms with significant translational potential in both pediatric and adult medicine, offering new avenues for precision therapeutics, functional nutrition, and biomarker discovery.
Zitieren
APA
Singh, D., & Singh, A. (2026). Milk-Derived Extracellular Vesicles as Multifunctional Therapeutic Platforms in Human Health, Nutrition, and Diagnostics. Recent Progress in Nutrition, 06(02), 1-43. https://doi.org/10.21926/rpn.2602007
Vancouver
Singh D, Singh A. Milk-Derived Extracellular Vesicles as Multifunctional Therapeutic Platforms in Human Health, Nutrition, and Diagnostics. Recent Progress in Nutrition. 2026;06(02):1-43. doi:10.21926/rpn.2602007
BibTeX
@article{Singh2026,
author = {Singh, Diwakar and Singh, Anita},
title = {Milk-Derived Extracellular Vesicles as Multifunctional Therapeutic Platforms in Human Health, Nutrition, and Diagnostics},
journal = {Recent Progress in Nutrition},
year = {2026},
volume = {06},
number = {02},
pages = {1--43},
doi = {10.21926/rpn.2602007}
}
EUVIMED